PE20130782A1 - Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo - Google Patents
Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismoInfo
- Publication number
- PE20130782A1 PE20130782A1 PE2012002483A PE2012002483A PE20130782A1 PE 20130782 A1 PE20130782 A1 PE 20130782A1 PE 2012002483 A PE2012002483 A PE 2012002483A PE 2012002483 A PE2012002483 A PE 2012002483A PE 20130782 A1 PE20130782 A1 PE 20130782A1
- Authority
- PE
- Peru
- Prior art keywords
- paracetamol
- preparation
- same
- pharmaceutical compositions
- compositions consisting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UNA COMPOSICION PARENTERAL QUE CONTIENE: A)PARACETAMOL EN UNA CONCENTRACION ACTIVA EN EL RANGO DE 166 A 250 mg/ml; B) UN SISTEMA DE DISOLVENTE QUE COMPRENDE GLICOFEROL DE 25 A 42% (V/V), ETANOL 10 A 37% (V/V),POLIETILENGLICOL 3 A 19% (V/V), Y AGUA CSP 2-3ml. TAMBIEN SE REFIERE A UN PROCESO FARMACEUTICO. DICHA COMPOSICION TIENE DOSIS TERAPEUTICAS DE PARACETAMOL UTIL EN EL TRATAMIENTO DE LA FIEBRE Y EL DOLOR, CON VISCOSIDAD DE 7 A 28 CPS, ADECUADA PARA LA ADMINISTRACION INTRAMUSCULAR E INTRAVENOSA.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3023MU2009 | 2010-06-30 | ||
IN630MU2010 | 2010-09-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20130782A1 true PE20130782A1 (es) | 2013-06-20 |
Family
ID=44514837
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2012002483A PE20130782A1 (es) | 2010-06-30 | 2011-06-29 | Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo |
PE2017000257A PE20170426A1 (es) | 2010-06-30 | 2011-06-29 | Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2017000257A PE20170426A1 (es) | 2010-06-30 | 2011-06-29 | Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo |
Country Status (26)
Country | Link |
---|---|
US (1) | US9616128B2 (es) |
EP (1) | EP2588097B1 (es) |
JP (1) | JP5872551B2 (es) |
KR (1) | KR101587942B1 (es) |
CN (1) | CN102958519B (es) |
AP (1) | AP3932A (es) |
AR (1) | AR083154A1 (es) |
AU (1) | AU2011273064B2 (es) |
BR (1) | BR112012031928B1 (es) |
CA (1) | CA2802303C (es) |
CO (1) | CO6592023A2 (es) |
CU (1) | CU20120178A7 (es) |
DK (1) | DK2588097T3 (es) |
EA (1) | EA023022B1 (es) |
ES (1) | ES2866636T3 (es) |
HU (1) | HUE054171T2 (es) |
IL (1) | IL222780A (es) |
MX (1) | MX2012014800A (es) |
MY (1) | MY156469A (es) |
PE (2) | PE20130782A1 (es) |
PL (1) | PL2588097T3 (es) |
PT (1) | PT2588097T (es) |
TW (1) | TWI538673B (es) |
UA (1) | UA109544C2 (es) |
WO (1) | WO2012001494A2 (es) |
ZA (1) | ZA201209674B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20121154A1 (it) * | 2012-06-29 | 2013-12-30 | Sint Sa | Soluzione iniettabile di acetaminofene per la somministrazione spinale |
JP6741286B2 (ja) * | 2013-03-28 | 2020-08-19 | テルモ株式会社 | 包装されたアセトアミノフェン注射液製剤の製造方法 |
US11266621B1 (en) | 2014-10-02 | 2022-03-08 | Exela Sterile Medicines Llc | Methocarbamol composition and related methods |
CN107205924A (zh) | 2014-12-20 | 2017-09-26 | 特罗伊卡药品有限公司 | 扑热息痛的可注射制剂 |
WO2022178018A1 (en) * | 2021-02-19 | 2022-08-25 | Nevakar Injectables Inc. | Liquid unit dosage forms for treatment of pain |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060052757A1 (en) * | 1996-06-04 | 2006-03-09 | Vance Products Incorporated, D/B/A Cook Urological Incorporated | Implantable medical device with analgesic or anesthetic |
FR2751875B1 (fr) * | 1996-08-05 | 1998-12-24 | Scr Newpharm | Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation |
ES2265470T3 (es) | 1997-11-18 | 2007-02-16 | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. | Soluciones farmaceuticas inyectables que contienen paracetamol y combinaciones de paracetamol con otras sustancias activas. |
IT1301976B1 (it) * | 1998-07-31 | 2000-07-20 | Angelini Ricerche Spa | Composizione farmaceutica iniettabile a base di paracetamolo |
JP2002522381A (ja) * | 1998-08-06 | 2002-07-23 | ストレンメル,ボルフガング | 粘膜保護用医薬としてのホスファチジルコリン |
IT1313579B1 (it) * | 1999-07-30 | 2002-09-09 | Acraf | Composizione farmaceutica liquida a base di paracetamolo. |
US20030152637A1 (en) * | 2001-01-25 | 2003-08-14 | Mark Chasin | Local anesthetic, and method of use |
AR067048A1 (es) * | 2007-06-18 | 2009-09-30 | Combino Pharm Sl | Formulaciones acuosas de acetaminofen para inyeccion. |
FR2926992B1 (fr) | 2008-02-06 | 2011-01-14 | Moly Pharma | Formulation d'une solution de paracetamol injectable,procede de preparation et de conditionnement d'une telle solution et dispositif de conditionnement d'une telle solution |
-
2011
- 2011-06-29 EP EP11746019.6A patent/EP2588097B1/en active Active
- 2011-06-29 WO PCT/IB2011/001519 patent/WO2012001494A2/en active Application Filing
- 2011-06-29 HU HUE11746019A patent/HUE054171T2/hu unknown
- 2011-06-29 PT PT117460196T patent/PT2588097T/pt unknown
- 2011-06-29 JP JP2013517570A patent/JP5872551B2/ja active Active
- 2011-06-29 MY MYPI2012004793A patent/MY156469A/en unknown
- 2011-06-29 AU AU2011273064A patent/AU2011273064B2/en not_active Ceased
- 2011-06-29 UA UAA201213891A patent/UA109544C2/ru unknown
- 2011-06-29 KR KR1020127032943A patent/KR101587942B1/ko active IP Right Grant
- 2011-06-29 US US13/806,541 patent/US9616128B2/en active Active
- 2011-06-29 DK DK11746019.6T patent/DK2588097T3/da active
- 2011-06-29 PE PE2012002483A patent/PE20130782A1/es not_active Application Discontinuation
- 2011-06-29 AP AP2012006645A patent/AP3932A/el active
- 2011-06-29 PL PL11746019T patent/PL2588097T3/pl unknown
- 2011-06-29 EA EA201291433A patent/EA023022B1/ru unknown
- 2011-06-29 MX MX2012014800A patent/MX2012014800A/es active IP Right Grant
- 2011-06-29 BR BR112012031928-0A patent/BR112012031928B1/pt active IP Right Grant
- 2011-06-29 PE PE2017000257A patent/PE20170426A1/es unknown
- 2011-06-29 ES ES11746019T patent/ES2866636T3/es active Active
- 2011-06-29 CN CN201180029973.2A patent/CN102958519B/zh active Active
- 2011-06-29 CA CA2802303A patent/CA2802303C/en active Active
- 2011-06-30 TW TW100123159A patent/TWI538673B/zh active
- 2011-06-30 AR ARP110102305A patent/AR083154A1/es unknown
-
2012
- 2012-10-31 IL IL222780A patent/IL222780A/en active IP Right Grant
- 2012-12-07 CO CO12222733A patent/CO6592023A2/es unknown
- 2012-12-20 ZA ZA2012/09674A patent/ZA201209674B/en unknown
- 2012-12-27 CU CU2012000178A patent/CU20120178A7/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR110986A2 (es) | Composiciones de ecteinascidina, formulaciones liofilizadas, método de preparación y uso | |
HRP20180007T1 (hr) | Formulacija koja sadrži gemcitabin-predlijek | |
EA201690102A1 (ru) | Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе | |
EA200501203A1 (ru) | Жидкие фармацевтические композиции палоносетрона | |
PH12017500136A1 (en) | Long-chain dimethylaniline derivative compounds, their preparation methods, self-assembled textures, and uses thereof | |
ECSP14023048A (es) | Agentes terapéuticos para administración subcutánea optimizados | |
AR101674A1 (es) | Uso de un compuesto tricíclico que contiene nitrógeno | |
PE20130782A1 (es) | Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo | |
AR062659A1 (es) | Composicion de liberacion sostenida de levodopa y metodo para su uso | |
ECSP16084317A (es) | Formulaciones farmacéuticas, procesos para la preparación y métodos de uso | |
PE20181332A1 (es) | Metodos de sedacion y formulacion parenteral para uso durante el tratamiento de cuidados criticos | |
BR112013010829B8 (pt) | Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação | |
CY1124893T1 (el) | Φαρμακευτικο μeιγμα μαροπιταντης | |
WO2015009731A3 (en) | Azacyclic constrained analogs of fty720 | |
UA93365C2 (ru) | Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты) | |
CO6470840A2 (es) | Formas farmacéuticas solubles de la n, n´-diaminodifenilsulfona para uso óptimo en el tratamiento de diversas enfermedades | |
PH12017501005A1 (en) | Injectable formulations of paracetamol | |
MX2018015759A (es) | Regimenes de dosificacion de vortioxetina para el rapido inicio del efecto antidepresivo. | |
AR074470A1 (es) | Compuesto de amida del acido ciclopropanocarboxilico, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de diabetes | |
MXPA06000760A (es) | Composicion farmaceutica estable de carisoprodol y meloxicam. | |
AR105087A1 (es) | Métodos para el tratamiento de mujeres con trastorno de deseo sexual hipoactivo (hsdd) con el tratamiento de combinación bupropión y trazodona | |
AR115724A1 (es) | Composición farmacéutica que contiene un péptido | |
EA201592261A1 (ru) | Фармацевтические композиции, включающие агомелатин в форме сокристаллов агомелатина с органической кислотой | |
BR112015022925A8 (pt) | Partículas de liberação estendida de resinato de fenilefrina, formulação farmacêutica, complexo de fármaco-resina e seu método de formação | |
CO2019013645A2 (es) | Dropropizina en combinación con ambroxol en la forma farmacéutica de jarabe y tabletas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |